JP2009542581A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542581A5
JP2009542581A5 JP2009512609A JP2009512609A JP2009542581A5 JP 2009542581 A5 JP2009542581 A5 JP 2009542581A5 JP 2009512609 A JP2009512609 A JP 2009512609A JP 2009512609 A JP2009512609 A JP 2009512609A JP 2009542581 A5 JP2009542581 A5 JP 2009542581A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
allopurinol
pharmaceutically acceptable
acceptable salt
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512609A
Other languages
English (en)
Japanese (ja)
Other versions
JP5028480B2 (ja
JP2009542581A (ja
Filing date
Publication date
Priority claimed from EP06011432A external-priority patent/EP1862166A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/055367 external-priority patent/WO2007138103A1/en
Publication of JP2009542581A publication Critical patent/JP2009542581A/ja
Publication of JP2009542581A5 publication Critical patent/JP2009542581A5/ja
Application granted granted Critical
Publication of JP5028480B2 publication Critical patent/JP5028480B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512609A 2006-06-01 2007-05-31 手足症候群の治療のためのアロプリノールの使用 Expired - Fee Related JP5028480B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06011432.9 2006-06-01
EP06011432A EP1862166A1 (en) 2006-06-01 2006-06-01 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
EP07107744.0 2007-05-08
EP07107744 2007-05-08
PCT/EP2007/055367 WO2007138103A1 (en) 2006-06-01 2007-05-31 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012118062A Division JP5389980B2 (ja) 2006-06-01 2012-05-23 手足症候群の治療のためのアロプリノールの使用

Publications (3)

Publication Number Publication Date
JP2009542581A JP2009542581A (ja) 2009-12-03
JP2009542581A5 true JP2009542581A5 (enExample) 2012-05-17
JP5028480B2 JP5028480B2 (ja) 2012-09-19

Family

ID=38512579

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009512609A Expired - Fee Related JP5028480B2 (ja) 2006-06-01 2007-05-31 手足症候群の治療のためのアロプリノールの使用
JP2012118062A Expired - Fee Related JP5389980B2 (ja) 2006-06-01 2012-05-23 手足症候群の治療のためのアロプリノールの使用
JP2013211700A Pending JP2014028851A (ja) 2006-06-01 2013-10-09 手足症候群の治療のためのアロプリノールの使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012118062A Expired - Fee Related JP5389980B2 (ja) 2006-06-01 2012-05-23 手足症候群の治療のためのアロプリノールの使用
JP2013211700A Pending JP2014028851A (ja) 2006-06-01 2013-10-09 手足症候群の治療のためのアロプリノールの使用

Country Status (21)

Country Link
US (3) US7973046B2 (enExample)
EP (1) EP2035006B1 (enExample)
JP (3) JP5028480B2 (enExample)
KR (1) KR101471022B1 (enExample)
AT (1) ATE457729T1 (enExample)
AU (1) AU2007267069B2 (enExample)
CA (1) CA2654270C (enExample)
CY (1) CY1110336T1 (enExample)
DE (1) DE602007004849D1 (enExample)
DK (1) DK2035006T3 (enExample)
ES (1) ES2341379T3 (enExample)
HR (1) HRP20100210T1 (enExample)
IL (1) IL195472A (enExample)
MX (1) MX2008015266A (enExample)
NZ (1) NZ573248A (enExample)
PL (1) PL2035006T3 (enExample)
PT (1) PT2035006E (enExample)
RS (1) RS51252B (enExample)
RU (1) RU2438673C2 (enExample)
SI (1) SI2035006T1 (enExample)
WO (1) WO2007138103A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246057A1 (en) * 2009-04-29 2010-11-03 Nobera Pharma, S.L. Use of allopurinol for the treatment of hand foot skin reaction
AU2010306671B2 (en) 2009-10-16 2015-12-17 Duke University Compositions and methods for the treatment of drug-induced hand-foot syndrome
EP2368549A1 (en) 2010-03-25 2011-09-28 BioAlliance Pharma Treating hand-foot syndrome and related pathologies using clonidine or its derivatives
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および/または治療剤
JP4983989B2 (ja) * 2010-03-31 2012-07-25 小野薬品工業株式会社 手足症候群の予防および治療剤
ES2604705T3 (es) * 2010-03-31 2017-03-08 Ono Pharmaceutical Co., Ltd. Agente preventivo y/o remedio para el síndrome mano-pie
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
EP2712613B1 (en) * 2012-09-28 2017-02-08 Pharmadab d.o.o. Vitamin K1 and uses thereof
WO2017168416A1 (en) * 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーOnquality Pharmaceuticals China Ltd. Egfr阻害に関連する疾患を予防又は治療する方法
AU2019254237B2 (en) 2018-04-16 2025-01-30 Onquality Pharmaceuticals China Ltd. Method for preventing or treating side effects of cancer therapy
RU2722396C2 (ru) * 2018-07-11 2020-05-29 Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") Способ лечения пальмарно-плантарной эритродизестезии

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011A (en) * 1843-03-21 Improvement in water-wheels
DE3772193D1 (de) 1987-02-13 1991-09-19 Allergan Pharma Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen.
JPH03106817A (ja) 1989-09-20 1991-05-07 Nippon Kayaku Co Ltd アロプリノール製剤
JPH066700A (ja) 1992-06-22 1994-01-14 Fujitsu General Ltd ハイビジョン受像機
GB9218711D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
WO1994005293A1 (en) 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja) 1993-11-02 2000-11-06 富士電機株式会社 漏電遮断器
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6060083A (en) 1999-04-01 2000-05-09 Topical Technologies, Inc. Topical DMSO treatment for palmar-plantar erythrodysethesia
DE50112233D1 (de) 2000-06-20 2007-05-03 Henkel Kgaa Verwendung von Vitamin B6-Derivaten zur Haarstrukturverbesserung
WO2002041837A2 (en) 2000-11-22 2002-05-30 Rxkinetix, Inc. Treatment of mucositis
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DE60232178D1 (de) * 2001-08-29 2009-06-10 Pharmakodex Ltd Vorrichtung zur topischen verabreichung
JP2005510537A (ja) * 2001-11-29 2005-04-21 サウンド・ファーマシューティカルズ・インコーポレイテッド 化学療法の所望されない効果を改善する方法および組成物
DE10200578A1 (de) * 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en) * 2002-02-12 2005-12-27 Ford John P Treatment method against side-effects of chemotherapy
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
AU2004247109A1 (en) 2003-06-11 2004-12-23 Novacea, Inc Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
CA2528378A1 (en) 2003-06-11 2004-12-23 Novacea, Inc. Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
US20050148833A1 (en) 2003-12-24 2005-07-07 Gregory Skover Apparatus containing a sensing element for the treatment of skin
AU2005218539A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP4405326B2 (ja) 2004-06-28 2010-01-27 株式会社東芝 ランドリー機器
ATE402709T1 (de) * 2004-09-17 2008-08-15 Biomas Ltd Neue tellurium-verbindungen und ihre verwendung als immunmodulatoren

Similar Documents

Publication Publication Date Title
JP2009542581A5 (enExample)
RU2008152341A (ru) Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии
WO2014078778A3 (en) Antiviral azasugar-containing nucleosides
JP2018193377A5 (enExample)
JP2014516942A5 (enExample)
JP2015515475A5 (enExample)
JP2010222367A5 (enExample)
JP2010525050A5 (enExample)
JP2015083580A5 (enExample)
JP2016106150A5 (enExample)
JP2009138003A5 (enExample)
JP2015524444A5 (enExample)
JP2010536849A5 (enExample)
JP2006508953A5 (enExample)
JP2013511534A5 (enExample)
JP2013518124A5 (enExample)
WO2011159100A2 (ko) 항암 활성을 나타내는 약제학적 조성물
JP2014508758A5 (enExample)
JP2014504636A5 (enExample)
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
Paccaly et al. Absence of clinically relevant drug interaction between delamanid, a new drug for multidrug-resistant tuberculosis (MDR-TB) and tenofovir or lopinavir/ritonavir in healthy subjects
JP2012525358A5 (enExample)
JP2011500589A5 (enExample)
JP2012508239A5 (enExample)
FI3919060T3 (fi) Ecopipam touretten oireyhtymän hoitoon